Search Within

Lara Dunn

Formats
  1. Meeting Abstract (81)
  2. Journal Article (50)
  3. Review (7)
  4. Book Section (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (141)
  2. Head and Neck Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Weinberg Fellows (141)
  5. Radiation Oncology, Department of (72)
  6. Surgery (65)

More Groups

People
  1. Eric Sherman (77)
  2. David Pfister (60)
  3. Nancy Lee (60)
  4. Sean McBride (57)
  5. Alan Ho (54)
  6. Nadeem Riaz (52)

More People

Years
  1. 2025 (3)
  2. 2024 (22)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. International Journal of Radiation Oncology, Biology, Physics (24)
  3. Annals of Oncology (9)
  4. Journal for ImmunoTherapy of Cancer (8)
  5. Head & Neck (6)
  6. Oral Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. Elsevier Inc. (30)
  3. Oxford University Press (10)
  4. Biomed Central Ltd (8)
  5. John Wiley & Sons, Inc. (6)
  6. Wiley Blackwell (6)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
    Journal Article

    Ho, A. L.; Dunn, L.; Sherman, E. J.; Fury, M. G.; Baxi, S. S.; Chandramohan, R.; Dogan, S.; Morris, L. G. T.; Cullen, G. D.; Haque, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma
    Journal Article

    Baxi, S. S.; Dunn, L. A.; Burtness, B. A.
    Oral Oncology (2016)

    Fulltext@MSK | Save
  • Combination of everolimus and sorafenib in the treatment of thyroid cancer: Update on phase II study
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Dunn, L.; Lee, J. S.; Lipson, B. L.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)
    Meeting Abstract

    Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Reply to B. O'Sullivan et al
    Journal Article

    Pfister, D. G.; Baxi, S. S.; Dunn, L. A.; Fury, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Therapy: Lenvatinib and radioiodine-refractory thyroid cancers
    Journal Article

    Dunn, L.; Fagin, J. A.
    Nature Reviews Endocrinology (2015)

    Fulltext@MSK | Save
  • Evaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer
    Journal Article

    Baxi, S. S.; Dunn, L.; Pfister, D. G.
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • Pan and palliative care
    Book Section

    Armendariz, R. T.; Stabler, S. M.; Dunn, L.; Moryl, N.; Forsberg, P.; Nikolova, T.; Saldivar, R.; Tickoo, R.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Use of intravaginal 17-ß estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; Dnistrian, A. M.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A. P.; Tucker, N.; Carter, J.; Barakat, R. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save